Options of dyslipidemia treatment at non-alcoholic fatty liver disease
Aim of review. To consider different treatment options for dyslipidemia in non-alcoholic fatty liver disease (NAFLD). Summary. NAFLD occurs in 20-30% of adult population. In the Russian Federation its rate is estimated as high as 37,1%. In the most of NAFLD cases severe disorder of lipid metabolism...
Saved in:
Main Authors: | M. V. Mayevskaya, M. A. Morozova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2018-08-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/71 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01) -
The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01) -
Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01) -
Metabolism of bile acids, liver diseases and microbiome
by: Yu. V. Yevsyutina, et al.
Published: (2018-08-01) -
Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)